Stock Rich List
Nasdaq: DMRA

Damora Therapeutics insiders

The officers, directors and 10% owners of Damora Therapeutics, Inc. who hold the most stock, valued at the live DMRA price.

$24.30
DMRA today +$1.3M (+5.74%)
Market closed. Prices as of Nov 19, 4:04 PM ET
Ranked insiders
2
Their DMRA stock
$18.9M
Market value
$1.50B
Held by ranked insiders
1.26%

Insiders by value of DMRA holdings

SEC ownership page
#InsiderRoleSharesValueOf companyOverall rank
1Jennifer JarrettDirector, President and CEO512,500$12.5M0.83%5980th
2L. Becker HewesChief Medical Officer264,629$6.4M0.43%12131st

Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Damora Therapeutics; see each profile for the filing.